ELITE PHARMACEUTICALS INC /NV/ ·
ELTP 8-K 2026-06-23
ELITE PHARMACEUTICALS INC /NV/ (ELTP) 8-K dated 2026-06-23 — accession 0001493152-26-029700. This URL is the filing, not the ELTP hub.
ELITE PHARMACEUTICALS INC /NV/ (ELTP) is a drug manufacturers - specialty & generic company listed on US.
ELITE PHARMACEUTICALS INC /NV/ filed a 8-K on 2026-06-23. Accession 0001493152-26-029700.
Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported ELTP revenue for 2026-03-31 was $148.9M. Net income was $44.9M. Revenue was up 77.1% from 2025-03-31 to 2026-03-31. ELTP currently screens at market cap $659.0M.
Not investment advice. The ELTP SEC hub lists recent forms. The stock page is the research view.